Levosimendan, an inotropic drug that potentiates ATP-dependent K+ channel and sensitise
troponin-C for calcium. It has positive effects in neurodegenerative diseases like Parkinson's …

Background: Levosimendan is a calcium sensitizer and phosphodiesterase inhibitor that has
potent antioxidant and anti-inflammatory activities. Objectives: The aim of the current study is …

Impairment of learning and memory has been associated with accumulation of reactive
oxygen species in the body. It has also been found that antioxidants enhance learning and …

Background: Parkinson's disease (PD) is a common neurodegenerative disorder that is
characterized by motor symptoms related to the deficiency in dopamine levels, and cognitive …

Aims Although approving new anticonvulsants was a major breakthrough in the field of
epilepsy control, so far we have met limited success in almost one third of patients suffering …

The study was aimed to assess the cognitive and protective potential of methanol extract of
Mimusops elengi bark (MEME-B) and flowers (MEME-F) against a mice model of the …

Background Levosimendan (Levo) is a drug commonly used to treat heart failure. Recent
studies have suggested that Levo may have neuroprotective effects, but it is still unknown …

The present study was designed to evaluate the effects of matrine (MAT) on scopolamine
(SCOP)-induced learning and memory impairment. After successive oral administration of …

Scopolamine is a well-known pharmacological agent responsible for causing memory
impairment in animals, as well as oxidative stress and neuroinflammation inducer which …

Simple Summary Cognitive deficits, including spatial working and recognition memory
impairment, are a common feature of Alzheimer's disease with current therapies offering …